Search

everythinglearnresearchcommunity

for

Search:↓

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Shift work disrupts the body's natural clock, leading to health problems.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

Different PCOS characteristics affect lipid profiles, increasing cardiovascular disease risk, so regular lipid screening is advised.

Metformin helps with PCOS symptoms no matter the patient's initial insulin resistance or weight.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

A combined strip and FUE method with careful planning improves hair restoration results.

The document concludes that cosmetic surgery is still mainly a practice for women and the gender gap in this field is expected to continue.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Young Finnish men with more severe hair loss may have higher inflammation and obesity, increasing future heart disease risk.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Some breast cancer chemotherapy can cause permanent hair loss.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Syphilis can cause hair loss that looks like other conditions, but it improves with treatment.

Women with Polycystic Ovary Syndrome have higher levels of the hormone ghrelin, which may be linked to the cause of the condition.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

The hHa7 gene is regulated by androgens in certain body hair, not scalp hair.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Body hair isn't a good substitute for scalp hair in steroid analysis.